Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine
Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine have?
Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine has 105 citations in the OpenAlex counts ScholarIQ stores.
When was Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine published?
Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine has 2024 year in the ScholarIQ index.
What is the open-access status of Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine?
Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine has hybrid oa status in the ScholarIQ index.
What is the DOI of Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine?
The DOI for Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine is on the source record.
What is the PMID of Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine?
The PMID for Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine is on the source record.
What is the OpenAlex record for Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine?
The OpenAlex for Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine is on the source record.